Home
Conditions
Vector Borne Diseases

Clinical trial condition

Vector Borne Diseases

Explore clinical trials studying Vector Borne Diseases. Study availability and eligibility vary by location and protocol.

2,038 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Vector Borne Diseases trial results

Completed

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

NCT00460486

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Centrum Badan Farmakologii Klinicznej monipol Krakow, Poland

Niepubliczny ZOZ "Atarax" s.c. Olsztyn, Poland

Niepubliczny ZOZ "VITA" Olsztyn, Poland

"PANTAMED" Sp. z o.o. Olsztyn, Poland

View Trial Details

Completed

Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health

NCT02669212

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +20 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Trial to Evaluate CIS43LS in Healthy Adults

NCT04206332

Conditions: Infections, Inflammation, Malaria, +9 more
Locations: University of Maryland Baltimore, Center for Vaccine Development Baltimore, Maryland, United States

VRC Clinic, NIH Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area

NCT03008122

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +6 more
Locations: Ponce School of Medicine CAIMED Center Ponce, Puerto Rico

View Trial Details

Completed

Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis

NCT03010228

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +12 more
Locations: eStudy Site La Mesa, California, United States

eStudySite La Mesa, California, United States

Celerion Inc. Lincoln, Nebraska, United States

Celerion, Inc Lincoln, Nebraska, United States

View Trial Details

Completed

Additional Screening With Sensitives RDTs and Malaria

NCT04147546

Conditions: Infections, Malaria, Malaria Diagnosis, +6 more
Locations: Institut de Recherche en Sciences de la Santé/ Clinical Research Unit of Nanoro Ouagadougou, Kadiogo, Burkina Faso

View Trial Details

Completed

Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F

NCT04238689

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Radboud University Medical Center Nijmegen, Gelderland, Netherlands

View Trial Details

Completed

Impact of Malaria on Pregnant Women in Ouelessebougou, Mali

NCT02974608

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Ouelessebougou Clinical Research Center (Malaria Research and Training Center) Bamako, Mali

View Trial Details

Completed

Cutaneous Leishmaniasis Diagnostic Study

NCT03837431

Conditions: Cutaneous Leishmaniases, Euglenozoa Infections, Infections, +9 more
Locations: Leishmania Research and Treatment Center, University of Gondar hospital Gonder, Ethiopia

View Trial Details

Completed

Single Low-dose Primaquine Efficacy and Safety.

NCT03352843

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Tropical Pesticides Research Institute (TPRI) Arusha, Tanzania

View Trial Details

Vector Borne Diseases

Vector Borne Diseases trial results

Related conditions